APPLICATION
BLA761458
TYPE
BLA
ORIGINAL APPROVAL
2025-12-16
LATEST ACTION
2026-06-10
ROUTE
SUBCUTANEOUS
DOSAGE FORM
INJECTION
MARKETING STATUS
Prescription
Products
EXDENSURPrescription
DEPEMOKIMAB-ULAA 100MG · INJECTION
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.